Exhibit 99.1 

Joint Filing Agreement

The undersigned hereby agree that the Statement on Schedule 13G dated January 27, 2023 with respect to the Common Stock, par value $0.0001 per share, of Jasper Therapeutics, Inc., and any amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.

Dated: January 27, 2023

Velan Capital Partners LP
By:	Velan Capital Holdings LLC General Partner
By:	/s/ Adam Morgan
	Name:	Adam Morgan
	Title:	Managing Member

Avego Healthcare Capital, L.P.
By:	Avego Healthcare Capital Holdings, LLC General Partner
By:	/s/ Balaji Venkataraman
	Name:	Balaji Venkataraman
	Title:	Managing Member

Velan Capital Holdings LLC
By:	/s/ Adam Morgan
	Name:	Adam Morgan
	Title:	Managing Member

Avego Healthcare Capital Holdings, LLC
By:	/s/ Balaji Venkataraman
	Name:	Balaji Venkataraman
	Title:	Managing Member

Avego Management, LLC
By:	/s/ Balaji Venkataraman
	Name:	Balaji Venkataraman
	Title:	Managing Member

Velan Capital Investment Management LP
By:	Velan Capital Holdings LLC General Partner
By:	/s/ Adam Morgan
	Name:	Adam Morgan
	Title:	Managing Member

Velan Capital Management, LLC
By:	/s/ Adam Morgan
	Name:	Adam Morgan
	Title:	Managing Member

/s/ Balaji Venkataraman

Balaji Venkataraman

/s/ Adam Morgan

Adam Morgan